India’s leading healthcare company Zylus Cadila has entered into a three-year collaboration with Sweden’s Karo Bio for developing new drugs for the treatment of inflammatory diseases. “We shall strive to introduce and develop novel, …

article continues at Krunal brought to you by diabetes.medtrials.info and medtrials.info